Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Theravance Biopharma, Inc. | 157,657 | reported | 20 Nov 2018 | tx 26+456,750−149,698 |
| Jazz Pharmaceuticals plc | 152,630 | reported | 05 Mar 2026 | tx 31+238,917−46,029 |
| Gossamer Bio, Inc. | 35,000 | reported | 08 Jun 2023 | tx 5+135,500 |
| CORCEPT THERAPEUTICS INC | 25,000 | reported | 20 Aug 2018 | tx 5+135,000 |
| DEXCOM INC | 12,486 | reported | 28 May 2026 | tx 4+17,560 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | GRANT_AWARD | DEXCOM INC | 5,605 | 0.00 USD | |
| 05 Mar 2026 | TAX_WITHHOLDING | Jazz Pharmaceuticals plc | 7,065 | 188.69 USD | |
| 26 Feb 2026 | GRANT_AWARD | Jazz Pharmaceuticals plc | 44,465 | 0.00 USD | |
| 16 Jan 2026 | TAX_WITHHOLDING | Jazz Pharmaceuticals plc | 5,371 | 171.16 USD | |
| 16 Jan 2026 | GRANT_AWARD | Jazz Pharmaceuticals plc | 12,741 | 0.00 USD | |
| 05 Dec 2025 | TAX_WITHHOLDING | Jazz Pharmaceuticals plc | 80 | 166.91 USD | |
| 07 Aug 2025 | GRANT_AWARD | Jazz Pharmaceuticals plc | 18,808 | 0.00 USD | |
| 08 May 2025 | GRANT_AWARD | DEXCOM INC | 5,074 | 0.00 USD | |
| 06 Mar 2025 | GRANT_AWARD | DEXCOM INC | 5,720 | 0.00 USD | |
| 05 Mar 2025 | OTHER | Jazz Pharmaceuticals plc | 5,704 | 138.95 USD | |
| 27 Feb 2025 | GRANT_AWARD | Jazz Pharmaceuticals plc | 11,555 | 0.00 USD | |
| 27 Feb 2025 | GRANT_AWARD | Jazz Pharmaceuticals plc | 23,111 | 0.00 USD | |
| 17 Jan 2025 | TAX_WITHHOLDING | Jazz Pharmaceuticals plc | 3,300 | 122.62 USD | |
| 17 Jan 2025 | GRANT_AWARD | Jazz Pharmaceuticals plc | 7,741 | 0.00 USD | |
| 05 Dec 2024 | TAX_WITHHOLDING | Jazz Pharmaceuticals plc | 80 | 123.45 USD | |
| 05 Apr 2024 | TAX_WITHHOLDING | Jazz Pharmaceuticals plc | 1,736 | 115.21 USD | |
| 05 Mar 2024 | TAX_WITHHOLDING | Jazz Pharmaceuticals plc | 3,622 | 117.53 USD | |
| 01 Mar 2024 | GRANT_AWARD | Jazz Pharmaceuticals plc | 19,916 | 0.00 USD | |
| 17 Jan 2024 | GRANT_AWARD | Jazz Pharmaceuticals plc | 7,079 | 0.00 USD | |
| 17 Jan 2024 | TAX_WITHHOLDING | Jazz Pharmaceuticals plc | 3,204 | 119.13 USD | |
| 10 Nov 2023 | GRANT_AWARD | Jazz Pharmaceuticals plc | 772 | 0.00 USD | |
| 08 Jun 2023 | GRANT_AWARD | Gossamer Bio, Inc. | 35,000 | 0.00 USD | deriv |
| 18 May 2023 | SALE | Jazz Pharmaceuticals plc | 6,000 | 131.75 USD | |
| 05 Apr 2023 | TAX_WITHHOLDING | Jazz Pharmaceuticals plc | 1,807 | 145.78 USD | |
| 03 Mar 2023 | GRANT_AWARD | Jazz Pharmaceuticals plc | 12,784 | 0.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 06 Mar 2018.